CeliVax Technology
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Original CeliVax Technology
- CeliVax uses patient-derived B cells, NK cells and monocytes.
- CeliVax is applicable to all cancers with identified antigens.
- CeliVax consists of Antigen Presenting Cells (APCs), tumor-associated antigen genes, and an adjuvant.
